These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 28749166)

  • 1. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
    Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
    Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
    Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
    Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
    Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
    Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
    [No Abstract]   [Full Text] [Related]  

  • 6. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
    Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
    Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases.
    Minami Y; Minami T; Chishina H; Kono M; Arizumi T; Takita M; Yada N; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
    Dig Dis; 2016; 34(6):687-691. PubMed ID: 27750238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging.
    Xu EJ; Lv SM; Li K; Long YL; Zeng QJ; Su ZZ; Zheng RQ
    Int J Hyperthermia; 2018 Sep; 34(6):870-876. PubMed ID: 28847188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors.
    Xu E; Long Y; Li K; Zeng Q; Tan L; Luo L; Huang Q; Zheng R
    Int J Hyperthermia; 2019 Jan; 35(1):159-167. PubMed ID: 30300032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
    Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
    Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar radiofrequency ablation for liver tumors: comparison of contrast-enhanced ultrasound with contrast-enhanced MRI/CT in the posttreatment imaging evaluation.
    Bo XW; Xu HX; Sun LP; Zheng SG; Guo LH; Lu F; Wu J; Xu XH
    Int J Clin Exp Pathol; 2014; 7(9):6108-16. PubMed ID: 25337258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
    Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
    BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
    Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
    Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
    Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound.
    Ju JX; Zeng QJ; Xu EJ; He XQ; Tan L; Huang QN; Li K; Zheng RQ
    Int J Hyperthermia; 2019; 36(1):785-793. PubMed ID: 31431086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.